NO158019C - Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolinderivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolinderivater.

Info

Publication number
NO158019C
NO158019C NO831318A NO831318A NO158019C NO 158019 C NO158019 C NO 158019C NO 831318 A NO831318 A NO 831318A NO 831318 A NO831318 A NO 831318A NO 158019 C NO158019 C NO 158019C
Authority
NO
Norway
Prior art keywords
sub
preparation
imidazoline derivatives
therapeutic active
analogy procedure
Prior art date
Application number
NO831318A
Other languages
English (en)
Other versions
NO158019B (no
NO831318L (no
Inventor
Michael Robin Stillings
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of NO831318L publication Critical patent/NO831318L/no
Publication of NO158019B publication Critical patent/NO158019B/no
Publication of NO158019C publication Critical patent/NO158019C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Lock And Its Accessories (AREA)
  • Vehicle Interior And Exterior Ornaments, Soundproofing, And Insulation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Paper (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO831318A 1982-04-17 1983-04-14 Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolinderivater. NO158019C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8211205 1982-04-17

Publications (3)

Publication Number Publication Date
NO831318L NO831318L (no) 1983-10-18
NO158019B NO158019B (no) 1988-03-21
NO158019C true NO158019C (no) 1988-06-29

Family

ID=10529762

Family Applications (1)

Application Number Title Priority Date Filing Date
NO831318A NO158019C (no) 1982-04-17 1983-04-14 Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolinderivater.

Country Status (24)

Country Link
US (1) US4446148A (no)
EP (1) EP0092328B1 (no)
JP (1) JPS58192882A (no)
AT (1) ATE27275T1 (no)
AU (1) AU552397B2 (no)
CA (1) CA1190932A (no)
CS (1) CS233746B2 (no)
DD (1) DD209628A5 (no)
DE (1) DE3371631D1 (no)
DK (1) DK160093C (no)
ES (1) ES521440A0 (no)
FI (1) FI73676C (no)
GB (1) GB2118548B (no)
GR (1) GR78528B (no)
HU (1) HU190894B (no)
IE (1) IE54922B1 (no)
IL (1) IL68318A (no)
NO (1) NO158019C (no)
NZ (1) NZ203680A (no)
PL (1) PL143658B1 (no)
PT (1) PT76558B (no)
SU (1) SU1217257A3 (no)
ZA (1) ZA832278B (no)
ZW (1) ZW8783A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4882343A (en) * 1987-08-28 1989-11-21 G. D. Searle & Co. Biarylalkylimidazole derivatives as anti-depressants
AU6307690A (en) * 1989-09-27 1991-04-11 Rhone-Poulenc Sante Imidazoles
FR2698789B1 (fr) * 1992-12-07 1995-03-03 Pf Medicament Utilisation de l'idazoxan et ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson et de son évolution.
FR2700113B1 (fr) * 1993-01-07 1995-03-24 Pf Medicament Utilisation de l'Idazoxan et ses dérivés pour la fabrication de médicaments destinés au traitement des maladies neurodégénératives et en particulier l'évolution de la maladie d'Alzheimer.
US6162455A (en) * 1997-01-22 2000-12-19 American Cyanamid Company Method for increasing lean meat, improving the lean meat to fat ratio and improving amino acid utilization in warm-blooded animals
FR2766824B1 (fr) * 1997-07-30 1999-09-10 Adir Nouveaux composes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2795727B1 (fr) * 1999-06-29 2001-09-21 Pf Medicament Nouveaux derives benzodioxanne imidazolines fluores, leur preparation et leurs applications en therapeutique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2979511A (en) * 1959-03-25 1961-04-11 Olin Mathieson Certain 1, 4-benzodioxanyl imidazolines and corresponding pyrimidines and process
PH16249A (en) * 1980-02-04 1983-08-16 Reckitt & Colmann Prod Ltd Imidazoline derivatives,its pharmaceutical composition and method of use
NZ199469A (en) * 1981-01-30 1984-03-16 Reckitt & Colmann Prod Ltd Benzodioxanyl-2-imidazoline derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
CS233746B2 (en) 1985-03-14
EP0092328A2 (en) 1983-10-26
EP0092328A3 (en) 1985-05-08
IL68318A0 (en) 1983-07-31
IE830858L (en) 1983-10-17
NO158019B (no) 1988-03-21
PL143658B1 (en) 1988-03-31
EP0092328B1 (en) 1987-05-20
ES8405394A1 (es) 1984-06-01
DK160093B (da) 1991-01-28
JPS58192882A (ja) 1983-11-10
FI831199L (fi) 1983-10-18
US4446148A (en) 1984-05-01
ES521440A0 (es) 1984-06-01
HU190894B (en) 1986-12-28
AU1329883A (en) 1983-10-20
GR78528B (no) 1984-09-27
NZ203680A (en) 1985-08-16
NO831318L (no) 1983-10-18
ZW8783A1 (en) 1983-07-06
IL68318A (en) 1986-07-31
FI73676C (fi) 1987-11-09
DK163783D0 (da) 1983-04-14
FI73676B (fi) 1987-07-31
ATE27275T1 (de) 1987-06-15
DE3371631D1 (de) 1987-06-25
SU1217257A3 (ru) 1986-03-07
PL241515A1 (en) 1984-07-30
ZA832278B (en) 1983-12-28
DD209628A5 (de) 1984-05-16
GB2118548B (en) 1985-07-31
CA1190932A (en) 1985-07-23
GB2118548A (en) 1983-11-02
AU552397B2 (en) 1986-05-29
DK163783A (da) 1983-10-18
PT76558B (en) 1986-01-21
JPH0427984B2 (no) 1992-05-13
FI831199A0 (fi) 1983-04-11
PT76558A (en) 1983-05-01
IE54922B1 (en) 1990-03-28
DK160093C (da) 1991-06-24

Similar Documents

Publication Publication Date Title
ATE61050T1 (de) Pyridazinamine wirksam gegen viren.
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
BG60249B2 (en) Thiazole compound for treatment of ulcers
NO851695L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-heteroaryl-tiazol-derivater
ES2052015T3 (es) Un metodo de preparacion de una composicion farmaceutica.
ATE21900T1 (de) Pyrimidinonderivate und diese enthaltende pharmazeutische zusammenstellungen.
NO854369L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzimidazol-derivater
NO158019C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolinderivater.
ATE53025T1 (de) 7-(2-(dialkylamino)ethly>-4-hydroxy-1,3benzimidazol-2-one.
NO164650C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-(acetylaminofenyl)-2-aminopropanon-derivater.
IL58999A (en) Pharmaceutical compositions comprising certain 2-(n-phenylhydroxyamino)imidazoline derivatives
NO167982C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive penemderivater.
NO170278C (no) Analogifremgangsmaate for fremstilling av nye antimykotiskvirksomme 2-(tioalkylamino)etyl-1h-imidazolderivater
JPS53124267A (en) 1-alkoxyacyl-3-(3,5-dihalogenophenyl)hydantoin derivatives, their preparation and bactericides for agricultural and horticultural uses containing the same as active agent
DK644487D0 (da) Farmaceutisk praeparat indeholdende en 2-oxo-imidazolidinforbindelse
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
ATE51227T1 (de) Chinatsalze der antimalarischen verbindung mefloquin.